Status:
COMPLETED
Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration
Lead Sponsor:
Medical University of Vienna
Conditions:
Abscess
Cysts
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Penetration of cefpirome and moxifloaxacin into abscess fluid of humans will be tested. Patients with an abscess scheduled for drainage will receive study drugs (single or multiple dose), pus samples ...
Detailed Description
Title: Plasma and abscess fluid pharmacokinetics of cefpirome and moxifloxacin single dose and multiple dose administration. Background: Extensive research in the field of abscess treatment has estab...
Eligibility Criteria
Inclusion
- Female or male, aged between 18 and 90 years.
- Written informed consent.
- Abscess formation or abdominal cyst scheduled to drainage.
- Plasma creatinine \<1.5 mg/dL
Exclusion
- Pregnancy or lactation.
- Hemodialysis or hemofiltration
- Allergy or hypersensitivity against study drugs
- Massive edemata or hypernatremia
- Reduced liver function (Child-Pugh A, B, C)
- Relevant prolongation of QT-interval
- CNS-diseases which predispose for cramps
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00280514
Start Date
January 1 2006
End Date
December 1 2009
Last Update
August 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Vienna
Vienna, Vienna, Austria, 1090